ACROBiosystems Group,founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. Our mission is to accelerate the progress of biopharmaceutical research and development to commercialization. To achieve this mission, our core values are established from a customer perspective by first satisfying our customers' needs for product quality. We have established a stringent quality management system to ensure our product quality and help our customers’ save time during drug development by meeting and exceeding customer expectations.
President and CEO of ACROBiosystems Group
This is one of our strategic decisions to ensure that the quality of products and services is guaranteed through a third-party audited, efficient, and standardized system. Through this approach, we were able to systematically standardize the entire production process of our products including recombinant proteins, antibodies, enzymes, cytokines, kits, and other products. A clear organizational structure and department functions are also established, specifying the relevant responsibilities and authorities of each position and necessary interactions. This is all implemented to ensure that our quality policy and objectives are implemented and achieved as expected.
By adopting the PDCA cycle and risk-based thinking, we are able to proactively respond to market competition,and are continuously striving to improve our overall efficiency on the basis of understanding the needs and expectations of interested parties, so as to improve customer satisfaction.
Based on our quality policy to ‘First focus on customer needs and applicable statutory and regulatory requirements to be an important and valued partner in the field of targeted therapies’, ACROBiosystems group is willing to cooperate with customers and suppliers to emphasize a collaborative environment for therapy development. Regarding quality controls, we have strictly implemented a comprehensive quality control process starting from drug substance to finished products, which includes 20+ advanced testing techniques, 30+ tests, 4 audits and 3 releases .
We launched GMP-grade products in early 2022, including cytokines, antibodies, enzymes, and magnetic beads for ex vivo cell culturing. These products are not only produced under a pharmaceutical-grade manufacturing plant, but are also designed and controlled under relevant domestic and international CGT regulations. Our products are produced under five interconnecting systems: material system, manufacturing system, facility/equipment system, packaging/labeling system, and laboratory quality control system. which comprehensively elaborates on the "true GMP ".
the basis and premise of complying with the relevant national or regional laws and regulations
• Social awareness: the purpose and social value of our company come from whether customers recognize and are satisfied with our work
• Service awareness: to guide daily work, provide services and create value for customers from the needs and concerns of external and internal customers
• Market awareness: to design products and service procedures and carry out other activities from the perspective of customers' reception and usage habits when carrying out work or making decisions
• Good profits and cash flows
• High operational efficiency and output
• Good brand awareness and customer relations
• Powerful support from our internal team
• Leading market dominance
Application-oriented development strategies
Over 95% of proteins are produced from HEK293 to ensure the native conformation of our proteins
Six guaranteed technology platforms for multi-pass transmembrane proteins, next-generation fluorescent site-directed labeling, and enzymology
Dedicated research & development brands including ActiveMax, GENPower, ViruStop, etc.
Custom products according to customer application requirements
Strict quality control systems
Strict quality and production process control
Validated analytical methodologies
DMF (FDA) filings for recombinant protein products
ISO9001 and ISO13485 certified
GMP quality management system
CNAS-accredited SPR testing services available
24h Technical support and free resources
24-hour technical support on weekdays
Free protocols on bioactivity validation
Open-access marketing information & training resources
Resources for monitoring clinical progress and market dynamics
Comprehensive regulatory support documentation
Extensive collaborations with our partners
Customers come first
1 to 5-day global shipping
Real-time, online support or local customer support available
Custom services available according to customer demands
Inventory reservation system to reserve the same batch or lot
If a Supplier Survey or Quality Statement is required, please click the buttoncontact us!